Effect of increased viral replication and infectivity enhancement on radioiodide uptake and oncolytic activity of adenovirus vectors expressing the sodium iodide symporter
Authors:
- J C MorrisJMJ C Morris
- 15 February 2013
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 20 (3) , 195-200
Abstract
Our laboratory has investigated replicating adenovirus-human sodium iodide symporter (Ad-hNIS) vectors in a combinatorial oncolytic approach known as radiovirotherapy. However, hNIS-mediated iodide sequestration requires an intact cell membrane, and the enhancement of infectivity may alter the radioiodide accumulation in vivo. To assess these effects, we constructed Ad-NIS vectors expressing NIS from the major late promoter. Viral tropism was altered using a hybrid Ad5/3 fiber, and rates of viral spread altered through expression of the Ad death protein (ADP). The hybrid 5/3 fiber enhanced Ad-mediated cytolysis and radioisotope uptake in vitro. Replicating ADP-lacking viral vectors showed levels of uptake similar to non-replicating vectors that declined as cells lysed. ADP expression enhanced the rate of cell lysis and viral release, but reduced the peak and duration of radioiodide uptake. SPECT-computed tomography imaging showed the Ad5/3-noADP-hNIS vector induced significantly more isotope uptake than other vector structures, indicating that viral spread may not always make up for the reduced NIS expression as in our work with prostate cancer. These results indicate that replicating, infectivity-enhanced Ad-NIS vectors provide superior overall efficacy, but also indicate that the effect of replication speed requires tumor and model-specific testing.Keywords
This publication has 30 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancerGene Therapy, 2010
- Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyCancer Gene Therapy, 2010
- Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancerBreast Cancer Research, 2009
- Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human ProstateMolecular Therapy, 2008
- Guidelines for radioiodine therapy of differentiated thyroid cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneBlood, 2007
- Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporterBlood, 2004
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene deliveryGene Therapy, 2000